In the Preventive Antibacterial Therapy in Acute Ischemic Stroke (PANTHERIS) trial Klehmet et al. [27] showed that increased levels of IL-10 were predictive for post-stroke infections independently of preventive antibacterial treatment with moxifloxacin. The gene discussed is IL10; the disease is stroke disorder.